Reference
[Please submit your publication]
|
Ohhara Y, Hoshino G, Imahori K, Matsuyuki T, Yamakawa-Kobayashi K. The Nutrient-Responsive Molecular Chaperone Hsp90 Supports Growth and Development in Drosophila. Front Physiol (2021) 12 690564
[
PubMed ID = 34239451
]
[
RRC reference
]
Mondal BC, Shim J, Evans CJ, Banerjee U. Pvr expression regulators in equilibrium signal control and maintenance of Drosophila blood progenitors. Elife (2014) 3 e03626
[
PubMed ID = 25201876
]
[
RRC reference
]
Sanders RD, Sefton JM, Moberg KH, Fridovich-Keil JL. UDP-galactose 4' epimerase (GALE) is essential for development of Drosophila melanogaster. Dis Model Mech (2010) 3(9-10) 628-38
[
PubMed ID = 20519568
]
[
RRC reference
]
Daenzer JM, Sanders RD, Hang D, Fridovich-Keil JL. UDP-galactose 4'-epimerase activities toward UDP-Gal and UDP-GalNAc play different roles in the development of Drosophila melanogaster. PLoS Genet (2012) 8(5) e1002721
[
PubMed ID = 22654673
]
[
RRC reference
]
|
Off-target search result
cv : coefficient of variation
(0 mm hits / total siRNA count)
mm : mismatch
|
cv |
0mm |
1mm |
2mm |
3mm |
target transcript |
off target name |
100 |
482 |
4 |
2 |
3 |
NM_138200.2 |
CG12030-RA (CG12030), mRNA |
0 |
0 |
4 |
3 |
5 |
NM_135135.3 |
CG9098-RA, transcript variant A (CG9098), mRNA |
0 |
0 |
4 |
2 |
4 |
NM_132956.1 |
CG9086-RA (CG9086), mRNA |
0 |
0 |
3 |
12 |
3 |
NM_139365.2 |
CG18330-RA (Cct2), mRNA |
0 |
0 |
3 |
3 |
10 |
NM_132111.2 |
CG4094-RA, transcript variant A (l(1)G0255), mRNA |
0 |
0 |
3 |
3 |
10 |
NM_167081.2 |
CG4094-RB, transcript variant B (l(1)G0255), mRNA |
0 |
0 |
2 |
5 |
3 |
NM_134498.2 |
CG14216-RA (CG14216), mRNA |
0 |
0 |
2 |
3 |
9 |
NM_205889.1 |
CG31665-RB, transcript variant B (CG31665), mRNA |
0 |
0 |
2 |
3 |
9 |
NM_164443.1 |
CG31665-RA, transcript variant A (CG31665), mRNA |
0 |
0 |
2 |
3 |
6 |
NM_140390.2 |
CG10725-RB (CG10725), mRNA |
0 |
0 |
2 |
2 |
5 |
NM_001038935.2 |
CG33989-RF, transcript variant F (pHCl), mRNA |
0 |
0 |
2 |
2 |
4 |
NM_001038936.2 |
CG33989-RE, transcript variant E (pHCl), mRNA |
0 |
0 |
2 |
2 |
4 |
NM_001038934.2 |
CG33989-RD, transcript variant D (pHCl), mRNA |
0 |
0 |
2 |
2 |
4 |
NM_001038937.1 |
CG33989-RC, transcript variant C (pHCl), mRNA |
0 |
0 |
2 |
2 |
3 |
NM_144017.1 |
CG18682-RA (CG18682), mRNA |
0 |
0 |
1 |
6 |
3 |
NM_166281.1 |
CG5170-RE, transcript variant E (Dp1), mRNA |
0 |
0 |
1 |
6 |
3 |
NM_166282.1 |
CG5170-RF, transcript variant F (Dp1), mRNA |
0 |
0 |
1 |
6 |
3 |
NM_166280.1 |
CG5170-RD, transcript variant D (Dp1), mRNA |
0 |
0 |
1 |
6 |
3 |
NM_206164.1 |
CG5170-RA, transcript variant A (Dp1), mRNA |
0 |
0 |
1 |
6 |
3 |
NM_079057.2 |
CG5170-RC, transcript variant C (Dp1), mRNA |
0 |
0 |
1 |
6 |
3 |
NM_206163.1 |
CG5170-RB, transcript variant B (Dp1), mRNA |
0 |
0 |
1 |
6 |
3 |
NM_079581.2 |
CG6538-RA (TfIIFbeta), mRNA |
0 |
0 |
1 |
4 |
2 |
NM_165935.1 |
CG8776-RB, transcript variant B (CG8776), mRNA |
0 |
0 |
1 |
4 |
2 |
NM_165936.1 |
CG8776-RC, transcript variant C (CG8776), mRNA |
0 |
0 |
1 |
4 |
2 |
NM_136964.2 |
CG8776-RE, transcript variant E (CG8776), mRNA |
0 |
0 |
1 |
4 |
2 |
NM_165934.1 |
CG8776-RA, transcript variant A (CG8776), mRNA |
0 |
0 |
1 |
4 |
2 |
NM_165937.1 |
CG8776-RD, transcript variant D (CG8776), mRNA |
0 |
0 |
1 |
3 |
9 |
NM_135344.2 |
CG8486-RA, transcript variant A (CG8486), mRNA |
0 |
0 |
1 |
3 |
9 |
NM_164795.2 |
CG8486-RB, transcript variant B (CG8486), mRNA |
0 |
0 |
1 |
3 |
9 |
NM_001042881.1 |
CG8486-RC, transcript variant C (CG8486), mRNA |
|